Canada markets closed

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.6400-0.0200 (-1.20%)
At close: 04:00PM EDT
1.6200 -0.02 (-1.22%)
After hours: 05:06PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts4444
Avg. Estimate-0.2-0.21-0.81-0.76
Low Estimate-0.24-0.25-0.86-1.01
High Estimate-0.17-0.16-0.72-0.36
Year Ago EPS-0.27-0.24-1.45-0.81
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts4444
Avg. Estimate16.69M16.93M71.93M62.27M
Low Estimate5.2M5.2M37.7M22.9M
High Estimate20.93M21.88M85.43M81.92M
Year Ago Sales20.5M24.14M90.12M71.93M
Sales Growth (year/est)-18.60%-29.90%-20.20%-13.40%
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.-0.28-0.2-0.21-0.19
EPS Actual-0.27-0.24-0.22-0.19
Difference0.01-0.04-0.010
Surprise %3.60%-20.00%-4.80%0.00%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.2-0.21-0.81-0.76
7 Days Ago-0.2-0.21-0.81-0.76
30 Days Ago-0.19-0.19-0.88-0.71
60 Days Ago-0.19-0.19-0.88-0.71
90 Days Ago-0.15-0.15-0.76-0.54
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days112N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNKTRIndustrySector(s)S&P 500
Current Qtr.25.90%N/AN/AN/A
Next Qtr.12.50%N/AN/AN/A
Current Year44.10%N/AN/AN/A
Next Year6.20%N/AN/AN/A
Next 5 Years (per annum)-7.30%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A